Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
| Last: | $26.02 |
|---|---|
| Change Percent: | -0.04% |
| Open: | $26.03 |
| Close: | $26.03 |
| High: | $26.05 |
| Low: | $26 |
| Volume: | 10,317 |
| Last Trade Date Time: | 10/08/2025 11:06:46 am |
| Market Cap: | $963,165,600 |
|---|---|
| Float: | 31,392,612 |
| Insiders Ownership: | N/A |
| Institutions: | 160 |
| Short Percent: | 924% |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://www.harrowinc.com |
| Country: | US |
| City: | Nashville |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Harrow Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
